शैडोइंग अभ्यास: Ataxia Series: Recognizing sporadic ataxias - YouTube के साथ अंग्रेजी बोलना सीखें

Hello and welcome to the MTS podcast,

⏸ रुका हुआ

गति:

235 वाक्य

यदि वाक्य बहुत छोटे या लंबे हों, तो समायोजित करने के लिए Edit पर क्लिक करें।

Hello and welcome to the MTS podcast,

the official podcast of the International Parkinson's Movement Disorder Society.

I am Orlando Barsatini, Professor of Neurology at Federal University of Sao Paulo, Brazil.

And today I'm here with Dr. Divyan Gahr.

Dr. Divyan is Assistant Professor at the Department of Neurology of OutIndia Institute of Medical Science,

New Valley, India.

And today we are discussing sporadic ataxia you can't miss.

Divyanne, thank you for joining us.

Hi, Orlando.

Thank you for having me.

It's truly a pleasure to be here and to discuss such a clinically important topic.

Iviane, my first question, how do you clinically distinguish sporadic from genetic ataxias at the bedside?

And tell me about the diagnostic pitfalls you commonly see in the evaluation of sporadic ataxia.

a great starting point.

At the bedside, I focus on three pillars,

age at onset, the temporal profile of progression of symptoms,

and the family history.

So genetic ataxias usually tend to have an insidious onset.

They tend to be slowly progressive.

And sometimes we find additional neurological features like neuropathy,

pyramidal signs, movement disorders, vision involvement.

It is also important to remember that the absence of family history does not exclude a genetic cause,

which can be due to various reasons like incomplete penetrance,

inaccurate diagnosis in the family member,

subtle symptoms in the family,

or even a small family size or de novo mutations.

So sporadic ataxias, the clues to that are that they usually have an acute to subacute onset,

or they may have a very rapidly progressive course.

And sometimes we will find history of systemic symptoms or history of exposure to drugs,

toxins, which can be great clues.

And some of the common pitfalls include assuming that chronic invariably means degenerative ataxia.

That is not true because we know for many of these sporadic ataxias,

a longer history may still be a part of the clinical spectrum.

Another pitfall is to miss sensory ataxia and assume

that all ataxia is actually cerebellar because sensory ataxias have a different set of etiologies.

Another pitfall would be to overlook medications that patient may be on and not screening adequately for immune or metabolic causes.

So the key principle is to never label degenerative or hereditary before excluding treatable causes.

As you said, we have many groups,

many different groups of sporadic taxis,

including infectious, metabolic, and ultimune.

Could you talk a little bit more about the treatable forms?

Yes, Orlando, absolutely.

And this is really the heart of the matter

because sporadic ataxias should always be approached with the mindset that it may be treatable unless proven otherwise.

So the treatable causes, as you have mentioned,

can be broadly categorized into immune-mediated causes.

Particularly important in these are the anti-GAD-associated ataxia,

gluten ataxia, the paraneoplastic cerebellar degenerations,

The infectious causes which are continuing to be important in some parts of the world,

for example, ataxias occurring in the setting of HIV,

syphilis, Whipple's disease, and then the JC virus which can cause progressive malifocal leucal encephalopathy,

which can occur either in immunocompromised or immunocompetent settings.

And then in children, the post-infectious cerebellitis is important,

which can follow several viral infections.

And then metabolic and nutritional causes,

of course, you must always screen for vitamin deficiencies and some specific electrolyte disturbances.

Toxins are important, particularly alcohol continues to remain the most common cause globally.

But it is also important to consider certain medications,

particularly the anti-seizure medications, chemotherapy agents.

And last but not the least,

I would also mention the structural causes like the tumors,

strokes, demyelinating disorders like multiple sclerosis,

etc. because these can be remedied either surgically or medically.

So if I had to summarize the approach to treatable sporadic ataxias,

I would emphasize three clues.

Of course, the subacute or rapidly progressive temporal profile,

the presence of systemic or extracerebellar features,

and a disproportion between clinical severity and imaging,

which we can talk about a little later.

Okay.

Diviani, when should clinicians suspect immune-mediated cerebral arotaxis?

And could you mention some clinical or radiological clues for this vaginosis,

especially immune-mediated cerebral arotoxic?

Yeah.

This is a crucial question because immune-mediated cerebellar ataxias are actually a very time-sensitive and potentially treatable cause of sporadic ataxia.

The earlier we intervene in these conditions,

the better is the neurological outcome because once cerebellar atrophy becomes evident and established,

reversibility tends to decline significantly.

So the clinicians should suspect immune-mediated etiologies primarily when the evolution is subacute,

meaning the clinical symptoms progress over a few weeks to a few months.

So a patient may report a history that they were walking normally three months ago,

let's say, and they are now needing support.

So that should immediately raise concerns for a potential immune-mediated etiology.

Other clues could be a presence of a personal or a family history of autoimmune disorders.

For example, there could be a family member who has autoimmune thyroid disorders,

type 1 diabetes, vitiligo, pernicious anemia,

celiac disease, etc. And then if you have the presence of some other associated neurological features like seizures,

myoclonus, stiff person syndrome, peripheral neuropathy,

behavioral changes, all of these raise clinical clues towards suspecting immune-mediated cerebellar ataxias.

You also asked about the radiology.

So from the radiological standpoint,

there's an important teaching point that the MRI of the brain can actually be completely normal in the early stages.

So therefore, normal MRI does not exclude immune mediated etiologies.

Okay, great.

Divyani, sometimes gluten ataxia is a controversial topic.

What features suggest gluten ataxia?

And in your vision, what are the most important diagnostic and treatment challenges in gluten ataxia?

Yes, Orlando.

Gluten ataxia is indeed one of the most debated areas in sporadic ataxias.

100

I do agree with you.

101

So basically, it's an immune-mediated cerebellar condition which is triggered by gluten sensitivity and can often occur independent of the gastrointestinal symptoms.

102

In fact, many patients may not have the classic features of celiac disease.

103

Clinically, one can suspect gluten ataxia in somebody who has a sporadic progressive cerebellar condition with predominantly a midline ataxia.

104

So there is predominantly gait and truncal ataxia,

105

a relatively pure cerebellar syndrome,

106

or sometimes one may have coexisting peripheral neuropathy or myoclonus.

107

The MRI may show vermeon predominant atrophy,

108

but as I told you earlier,

109

the early imaging may be normal.

110

So a good clue here becomes to look at the MR spectroscopy of the vermis,

111

which may show a reduced NAA is to creatinine ratio.

112

And like you mentioned, the challenges are actually substantial in gluten ataxia.

113

The antibody testing is imperfect.

114

We rely on a whole host of antibodies

115

and there is a lot of debate about which antibodies are most neurologically relevant as opposed to most gastrointestinally relevant.

116

Then there are patients who may be zero negative but they are very clinically concerning for gluten.

117

So this may raise challenges about whether to initiate a strict gluten-free diet

118

or not and there are no universally standardized diagnostic criteria for gluten ataxia.

119

So that creates a problem itself.

120

Diviani, now I have another sensitive point in the study of ataxia.

121

What pathophysiological mechanism explains selective cerebellar degenerative in nutritional deficient related A-tacta?

122

And which deficients are the most frequently overlooked in the clinical practice?

123

This is a fascinating and a very important area.

124

So the cerebellum, as you know,

125

especially the the Purkinje cells,

126

they are metabolically highly active and they are particularly vulnerable to metabolic stress.

127

So these neurons have extensive dendritic connections and they have very high firing rates.

128

So that makes them especially sensitive to mitochondrial dysfunction,

129

oxidative stress or any other form of energy deficit.

130

So nutritional deficiencies tend to interfere either directly or indirectly with these pathways.

131

And some of the commoner nutritional deficiencies are triggered by thymine deficiency

132

that may occur in the setting of chronic alcohol use but that's pretty well known.

133

But some of the less common or overlooked deficiencies might be deficiency of vitamin b12,

134

copper and vitamin E all of which tend to cause sensory ataxia rather than cerebellar ataxia.

135

And another important deficiency which we should think of particularly

136

when there is a setting of chronic vomiting or proton pump inhibitor use

137

or a GI surgery would be a deficiency of magnesium.

138

And this is a really important cause of cerebellar ataxia,

139

where patients can present with severe ataxia,

140

classically with a downbeating nystagmus.

141

And the MRI may show a typical involvement of the nodulus,

142

or it may show cerebellar vasogenic edema.

143

It's really important to recognize magnesium deficiency because quick supplementation can lead to dramatic recovery.

144

Divini, another important point is sporadic cataxia are quite complex.

145

Which toxic or drug-induced ataxia are commonly overlooked in the clinical practice.

146

I believe that this is a quite important point.

147

I absolutely agree with you because drug-induced and toxic ataxias are probably more common than we recognize,

148

and they are very frequently reversible if they're recognized early.

149

So, of course, chronic alcohol exposure,

150

it is difficult to overlook it,

151

but sometimes patients may minimize intake,

152

So it's important to be careful and take a non-judgmental history.

153

It's important to recognize this because it can lead to permanent cerebellar damage, alcoholic cerebellar degeneration.

154

But in terms of the drug,

155

some of the important drugs that I want to talk about are the anti-seizure medications.

156

So we do know that the older generation anti-seizure medications like phenytoin,

157

babichirates, benzodiazepines, and all of that can result in cerebellar atrophy.

158

And they continue to be used in many regions of the world.

159

So chronic exposure to these can lead to permanent cerebellar atrophy.

160

But even among the newer antiseizure medications like gabapentin,

161

pregabalin, lamotrigine, many of them are known to trigger ataxia,

162

vertigo, tremors as side effects.

163

The other group of drugs that we must not miss is antibiotics,

164

particularly metronirazole, because that is often used for gastrointestinal infections.

165

and a high cumulative dose can precipitate subacute cerebellar syndromes.

166

And then sometimes we have clear exposures to drugs like lithium,

167

chemotherapeutic agents like cytarabine and immune checkpoint inhibitors increasingly that are being used for the treatment of cancer.

168

And then in certain occupations,

169

one can have heavy metal exposures like mercury or lead.

170

So these might be some of the overlooked causes,

171

but definitely are eminently reversible with reduction of exposure.

172

Divini, how do sensory neuronopathy-associated ataxia alter the diagnostic approach compared,

173

for example, with pure cerebellar syndromes?

174

This is a very relevant question clinically,

175

because profound proprioceptive loss can mimic cerebellar ataxia,

176

but the close there would be a worsening of the ataxia in darkness,

177

presence of pseudoathetosis and importantly there would be a preservation of the eye movements in speech

178

because these two latter are mediated directly by the cerebellum

179

so we don't expect these to be abnormal in a proprioceptive pathway dysfunction.

180

Nerve conduction studies are essential and it's important to differentiate clinically sensory from cerebellar ataxias

181

because of the list of causes for sensory neuronopathy.

182

So the usual causes include paraneoplastic syndromes,

183

Jogren's syndrome, chemotherapy agents, B12 deficiency,

184

and increasingly being recognize the immune mediated neuropathies like the nodalopathies and the paranodalopathies.

185

So recognizing sensory ataxia actually shifts the diagnostic work up towards peripheral and systemic causes.

186

And which systemic alt-immune or endocrine disorder should be routinely screened for an ex-premate sporoidic ataxia?

187

So this really depends on the clinical context,

188

but I would routinely screen for thyroid dysfunction,

189

antithyroid antibodies, celiac serology, anti-GAD antibodies,

190

and then the autoimmune markers,

191

paraneoplastic markers, HIV serology, and B12 deficiency.

192

So these are relatively low cost tests with a high diagnostic yield in selected patients.

193

So this would be a very basic screening for sporadic ataxias.

194

Okay.

195

And regarding treatment, which clinical or biomarker features predict the immunotherapy response in all the new cerebellar attacks, the DVNA.

196

This is a very important question,

197

Orlando, because I just want to mention that time is cerebellum.

198

So when we initiate therapy early,

199

there is a potential to salvage the cerebellar reserve and improve the neurological deficits.

200

The predictors to response to immunotherapy,

201

as you asked, would include a shorter duration of symptoms,

202

a subacute onset, presence of an MRI being normal rather than an MRI showing cerebellar atrophy,

203

presence of surface antibodies as compared to the intracellular onconeural antibodies,

204

and of course, early treatment initiation.

205

Okay.

206

Divyami, this is my last question.

207

It's probably the most important question.

208

What is the diagnostic algorithm for sporadic ataxia that the treatable ones are not missing?

209

I think this is the core question.

210

So my structured approach is to first confirm whether it's a cerebellar ataxia or a sensory ataxia or a vestibular ataxia.

211

This would of course be deciphered by a good history and a clinical examination.

212

Determine the temporal profile and progression of symptoms,

213

whether it's are rapidly progressive, subacute.

214

Then take a targeted history of exposure to drugs and toxins.

215

Don't forget this because this sometimes gets overlooked.

216

Perform a good MRI of the brain.

217

You must also try to see whether radiological involvement is proportionate to the degree of clinical involvement

218

because if you find a lot of clinical dysfunction but not so much of radiological findings,

219

that's a good clue towards thinking of immune-mediated ataxias.

220

Order some basic laboratory screening like we mentioned earlier,

221

that is the routines, thyroid functions, vitamin levels.

222

Then pursue targeted autoimmune, paraneoplastic,

223

or infectious testing depending on the clinical context.

224

Also consider genetic testing only after these treatable causes are excluded.

225

So the guiding principle is simple,

226

exclude reversible causes before labeling the patient with a degenerative disorder.

227

Okay, thank you Diviani for sharing these insights and thank you to our listeners for joining us.

228

We hope this episode helped you approach sporadic attacks with greater confidence and precision.

229

Thank you.

230

Thank you, Orlando.

231

The views

232

and opinions expressed by the participants in this podcast do not necessarily reflect those of the International Parkinson

233

and Movement Disorders Society or their affiliated journals,

234

Movement Disorders and Movement Disorders Clinical Practice.

235

Any disclosures of the participants can be found within the episode description located on the MDS website.

TRENDING

शैडोइंग तकनीक क्या है?

शैडोइंग (Shadowing) एक विज्ञान-समर्थित भाषा सीखने की तकनीक है जो मूल रूप से पेशेवर दुभाषिया प्रशिक्षण के लिए विकसित की गई थी। विधि सरल लेकिन शक्तिशाली है: आप मूल अंग्रेज़ी ऑडियो सुनते हैं और तुरंत इसे ज़ोर से दोहराते हैं — जैसे वक्ता की छाया 1-2 सेकंड की देरी से। शोध से पता चलता है कि यह उच्चारण सटीकता, स्वर, लय, जुड़ी हुई ध्वनियाँ, सुनने की समझ और बोलने की प्रवाहशीलता में काफ़ी सुधार करता है।

☕ हमें एक कॉफी पिलाएं

आपके समर्थन के कारण ShadowingEnglish 100% मुफ्त है। सर्वर और AI की लागत अधिक है — आपकी कॉफी हमें आगे बढ़ने में मदद करती है! 🙏

PayPal के माध्यम से दान करें

ShadowingEnglish.com – अंग्रेज़ी शैडोइंग अभ्यास

शैडोइंग अभ्यास: Ataxia Series: Recognizing sporadic ataxias - YouTube के साथ अंग्रेजी बोलना सीखें

लोकप्रिय

संदर्भ और पृष्ठभूमि

दैनिक संचार के लिए शीर्ष 5 वाक्यांश

कदम-दर-कदम शैडोइंग गाइड

शैडोइंग तकनीक क्या है?

शैडोइंग अभ्यास: Ataxia Series: Recognizing sporadic ataxias - YouTube के साथ अंग्रेजी बोलना सीखें

ऐप डाउनलोड करें

संदर्भ और पृष्ठभूमि

दैनिक संचार के लिए शीर्ष 5 वाक्यांश

कदम-दर-कदम शैडोइंग गाइड

शैडोइंग तकनीक क्या है?